Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study

Julie E. Bauman, Sana D. Karam, Cathy O'Brien, Gabriel Mak, Byoung Chul Cho

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Durvalumab in combination with chemoradiotherapy in patients with head and neck squamous cell carcinoma: Results from the Phase 1 CLOVER study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases